BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15841177)

  • 1. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
    Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
    J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.
    Schmidt E; Wehr B; Tabengwa EM; Reimer S; Bröcker EB; Zillikens D
    Clin Exp Immunol; 2004 Mar; 135(3):497-504. PubMed ID: 15008985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin is not protective in experimental renal interstitial fibrosis.
    Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
    Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
    Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
    Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.
    Liu Z; Shipley JM; Vu TH; Zhou X; Diaz LA; Werb Z; Senior RM
    J Exp Med; 1998 Aug; 188(3):475-82. PubMed ID: 9687525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of different pathways of the complement cascade in experimental bullous pemphigoid.
    Nelson KC; Zhao M; Schroeder PR; Li N; Wetsel RA; Diaz LA; Liu Z
    J Clin Invest; 2006 Nov; 116(11):2892-900. PubMed ID: 17024247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.
    Liu Z; Zhou X; Shapiro SD; Shipley JM; Twining SS; Diaz LA; Senior RM; Werb Z
    Cell; 2000 Sep; 102(5):647-55. PubMed ID: 11007483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
    Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
    J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin wound healing in MMP2-deficient and MMP2 / plasminogen double-deficient mice.
    Frøssing S; Rønø B; Hald A; Rømer J; Lund LR
    Exp Dermatol; 2010 Aug; 19(8):e234-40. PubMed ID: 20163454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
    Leighty L; Li N; Diaz LA; Liu Z
    Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.
    Lin L; Bankaitis E; Heimbach L; Li N; Abrink M; Pejler G; An L; Diaz LA; Werb Z; Liu Z
    J Biol Chem; 2011 Oct; 286(43):37358-67. PubMed ID: 21880713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
    Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.